(Q45770666)

15 December 2017

title

Suboptimal dosing of Strattera (atomoxetine) for ADHD patients (English)

1 reference

15 December 2017

1 reference

David B Clemow

1

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 September 2014

1 reference

15 December 2017

published in

Postgraduate Medicine

1 reference

15 December 2017

volume

126

1 reference

15 December 2017

issue

5

1 reference

15 December 2017

page(s)

196-198

1 reference

15 December 2017

Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2014.09.2814

Atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2014.09.2814

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2014.09.2814

Clinical practice. Attention deficit-hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2014.09.2814

Atomoxetine tolerability in pediatric and adult patients receiving different dosing strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2014.09.2814

Once-daily atomoxetine for treating pediatric attention-deficit/hyperactivity disorder: comparison of morning and evening dosing.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2014.09.2814

Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month, double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2014.09.2814

21 January 2018

Identifiers

DOI

10.3810/PGM.2014.09.2814

1 reference

15 December 2017

1 reference

15 December 2017